Back to Acceleration Radar
ADUSAddus HomeCare Corporation
Health Care · Medical/Nursing Services · Mid
$121.81−0.70%
As of 23 Oct 2026Mkt cap $2.2B
Stage 13
WATCH
Fundamentals
49.7/75
Technical
5.7/15
Independent
55.4/90
GCAE viewbusiness is credible but technical recovery is not yet actionable
Price
- 1M
- +6.8%
- 3M
- +5.3%
- 6M
- +27.3%
- 1Y
- +0.3%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 21.4xHist median 24.3x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- —
- FCF yield
- —
Quality
- ROIC
- 7.8%
- Operating margin
- 8.9%
- FCF margin
- 7.3%
- Current ratio
- 1.8x
Growth
- Revenue growth
- +23.2%Latest FY YoY
- Revenue CAGR
- +13.3%
- EPS CAGR
- +16.7%
- FCF CAGR
- +31.4%
Capital
- Share-count trend
- +6.2%3Y annualised
- Net debt
- $72M0.6x OCF
Annual trend
- CAGR 2021–2025
- +13.3%
- Latest · 2025
- $1B
- YoY
- +23.2%
GCAE Research
- Quality Research
- PRE-AI
- Acceleration Radar
- FUNDAMENTAL GATE FAIL
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- NOT FLAGGED
Key takeaway
business is credible but technical recovery is not yet actionable
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2026-11-03
More details & evidence
Production decision
- Stage 13
- WATCH
- Technical state
- approaching-support
- Rotation
- tailwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- CURRENT
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded